Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

NASDAQ:TOUR - Nasdaq - US89977P1066 - ADR - Currency: USD

0.9  +0.01 (+1.12%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TOUR. TOUR was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of TOUR get a neutral evaluation. Nothing too spectacular is happening here. TOUR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TOUR was profitable.
TOUR had a positive operating cash flow in the past year.
TOUR had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TOUR reported negative operating cash flow in multiple years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

The Return On Assets of TOUR (4.03%) is better than 62.60% of its industry peers.
TOUR has a better Return On Equity (7.12%) than 64.12% of its industry peers.
TOUR has a Return On Invested Capital of 6.07%. This is comparable to the rest of the industry: TOUR outperforms 56.49% of its industry peers.
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROIC 6.07%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

TOUR's Profit Margin of 14.98% is amongst the best of the industry. TOUR outperforms 88.55% of its industry peers.
TOUR's Operating Margin of 15.18% is fine compared to the rest of the industry. TOUR outperforms 67.18% of its industry peers.
TOUR has a Gross Margin of 69.65%. This is amongst the best in the industry. TOUR outperforms 84.73% of its industry peers.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

6

2. Health

2.1 Basic Checks

TOUR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TOUR has less shares outstanding
Compared to 5 years ago, TOUR has less shares outstanding
TOUR has a better debt/assets ratio than last year.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

TOUR has an Altman-Z score of -4.76. This is a bad value and indicates that TOUR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TOUR (-4.76) is worse than 93.89% of its industry peers.
There is no outstanding debt for TOUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -4.76
ROIC/WACC0.65
WACC9.41%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

TOUR has a Current Ratio of 1.35. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR's Current ratio of 1.35 is fine compared to the rest of the industry. TOUR outperforms 68.70% of its industry peers.
TOUR has a Quick Ratio of 1.35. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.35, TOUR is doing good in the industry, outperforming 71.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

TOUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.78%, which is quite impressive.
TOUR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.45%.
The Revenue for TOUR have been decreasing by -25.77% on average. This is quite bad
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%

3.2 Future

TOUR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -21.60% yearly.
TOUR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.31% yearly.
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

4

4. Valuation

4.1 Price/Earnings Ratio

TOUR is valuated reasonably with a Price/Earnings ratio of 10.00.
95.42% of the companies in the same industry are more expensive than TOUR, based on the Price/Earnings ratio.
TOUR is valuated cheaply when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 79.14 indicates a quite expensive valuation of TOUR.
Based on the Price/Forward Earnings ratio, TOUR is valued a bit more expensive than the industry average as 65.65% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.71, TOUR is valued quite expensively.
Industry RankSector Rank
PE 10
Fwd PE 79.14
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOUR is valued a bit cheaper than the industry average as 76.34% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TOUR indicates a rather cheap valuation: TOUR is cheaper than 95.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.05
EV/EBITDA 8.91
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as TOUR's earnings are expected to decrease with -21.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%

3

5. Dividend

5.1 Amount

TOUR has a Yearly Dividend Yield of 3.33%.
TOUR's Dividend Yield is rather good when compared to the industry average which is at 3.64. TOUR pays more dividend than 86.26% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, TOUR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

TOUR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

TUNIU CORP-SPON ADR

NASDAQ:TOUR (7/23/2025, 11:53:03 AM)

0.9

+0.01 (+1.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)06-02 2025-06-02
Earnings (Next)08-04 2025-08-04
Inst Owners9.95%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap105.94M
Analysts85.71
Price Target1.73 (92.22%)
Short Float %0.41%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10
Fwd PE 79.14
P/S 1.48
P/FCF 9.05
P/OCF 7.92
P/B 0.7
P/tB 0.78
EV/EBITDA 8.91
EPS(TTM)0.09
EY10%
EPS(NY)0.01
Fwd EY1.26%
FCF(TTM)0.1
FCFY11.05%
OCF(TTM)0.11
OCFY12.63%
SpS0.61
BVpS1.28
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROCE 7.68%
ROIC 6.07%
ROICexc 6.07%
ROICexgc 6.82%
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
FCFM 16.34%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-Score8
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 192.93%
Cap/Sales 2.33%
Interest Coverage 26.17
Cash Conversion 113.99%
Profit Quality 109.09%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -4.76
F-Score8
WACC9.41%
ROIC/WACC0.65
Cap/Depr(3y)99.5%
Cap/Depr(5y)69.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A
EBIT growth 1Y477.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year526.7%
EBIT Next 3Y112%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A